DeLorean AI

DeLorean AI is a private healthcare artificial intelligence company focused on predictive analytics for insurers and care providers. Its flagship platform, MARTI (Medical Artificial Real Time Intelligence), is used to identify undiagnosed disease, predict disease progression and care transitions, stratify patient risk, and recommend next-best clinical actions. The company markets disease-specific care modules spanning renal disease, diabetes, cardiovascular disease, behavioral health, and respiratory conditions, with the goal of lowering medical costs and improving outcomes in value-based care settings. DeLorean AI appears to operate primarily as a healthcare software and analytics company rather than a drug-development biotech, and there is no evidence of a therapeutic pipeline in the traditional pharma sense.